Pressmeddelande -
FrostPharma is now further strengthening the organization through the recruitment of Rebecka Grund as COO.
Rebecka brings a wealth of experience to FrostPharma having held both hands-on commercial accountabilities, as well as complex multinational performance-enhancing roles in the pharma industry. Rebecka will be an important cornerstone to the FrostPharma Management Team, at the same time as she will add proven leadership to the already very experienced commercial Pharma team that Frost has attracted and retained since start.
Rebecka joins FrostPharma in a period of fast growth, with multiple new product launches over the coming 12 months. In parallel to multiple product launches, we are also expanding the FrostPharma geographic reach. With Rebecka and her excellent team, we have strengthened the leadership and capability to deliver our portfolio- and market expansion with confidence, both now and for the future.
About FrostPharma:
FrostPharma is an entrepreneurial Swedish Specialty Pharma company specializing in the commercialization of value-adding medicines. FrostPharma signed its first product distribution agreement in 2017, and since then 35 products have been added to the therapy agnostic portfolio through a strong agreement deal-flow, as well as through the development of proprietary products. The company has an established specialty pharma platform across the Nordics, and now actively plan to expand to additional EU countries. The FrostPharma portfolio of products are primarily oriented toward hospital use, and hospital initiation. FrostPharma has also developed a separate division offering sustainable solutions to petroleum based plastics across the Healthcare sector.
Relaterade länkar
Ämnen
FrostPharma AB, med säte i Danderyd, Sverige, ett svenskt snabbväxande läkemedelsföretag med fokus på kommersialisering och tillgängliggörandet av värdeskapande specialist och sjukhusläkemedel.
FrostPharma har dessutom utvecklat ett separat affärsområde som erbjuder hälso- och sjukvården, laboratorium och läkemedelsindustri klimatsmarta hållbara produkter som alternativ till de petroleumbaserade plastprodukter sjukvården använder idag. Dessa produkter tillverkas i Sverige av biokomposit och bioplast och erbjuder hälso- och sjukvård en signifikant reduktion av klimatpåverkande utsläpp.
